Pharma CMO M&A activity shifts focus to scaling in 2023: GlobalData GlobalData Aug 20, 2024 High inflation and interest rates along with an uncertain business environment have disincentivised investment. The focus shifts…
Baxter to divest biopharma solutions business to Advent International and Warburg Pincus for $4.25… EP News Bureau May 9, 2023 Net proceeds planned to be redeployed for debt repayment in accordance with Baxter’s stated capital allocation priorities
